Key result
Severe obesity linked to ~2.3-fold higher risk of new-onset heart failure after AF ablation.
Why the study?
Although catheter ablation for AF reduces HF progression, some patients remain at risk for incident HF afterward, and the relationship between BMI and new-onset HF after AF ablation required investigation.
Does elevated body mass index increase the risk of new-onset heart failure in patients undergoing first-time catheter ablation for atrial fibrillation?
Cohort (n=7,363)
Yes
Does elevated body mass index increase the risk of new-onset heart failure in patients undergoing first-time catheter ablation for atrial fibrillation?
Elevated BMI is an independent, dose-dependent predictor of incident heart failure following first-time catheter ablation for atrial fibrillation, highlighting the need for continued weight and cardiovascular risk management post-ablation.
Answers are grounded in this paper and cite their sources.
Severe obesity may warrant closer post-ablation HF surveillance; leaves open whether weight loss modifies risk.
Background Atrial fibrillation (AF) is the most common arrhythmia and a major contributor to heart failure (HF). While catheter ablation (CA) reduces HF progression, some patients remain at risk for incident HF after ablation. This study aims to analyze the relationship between body mass index (BMI) and new-onset HF in patients undergoing CA for AF. Methods We retrospectively studied patients from the MGH Research Patient Data Registry who underwent first-time CA for AF from January 2013 to August 2024. The primary outcome was new-onset HF. Cox regression identified independent predictors, and Kaplan–Meier analysis assessed HF-free survival across BMI categories. Results Among 7,363 patients, 550 (7.5%) developed HF during 3.6 ± 2.9 years of follow-up. HF-free survival declined across increasing BMI categories. At 10 years, HF-free survival was 94.2% for BMI <25 and 86.3% for BMI ≥40. Independent predictors of HF included age ≥75 years (HR 1.79, 95% CI 1.45–2.22), female sex (HR 1.41, 95% CI 1.16–1.73), hypertension (HR 1.28, 95% CI 1.03–1.59), ischemic heart disease (HR 1.44, 95% CI 1.19–1.74), mitral regurgitation (HR 2.60, 95% CI 2.07–3.27), aortic stenosis (HR 1.97, 95% CI 1.38–2.80), pulmonary hypertension (HR 3.02, 95% CI 2.26–4.05), pulmonary embolism (HR 1.99, 95% CI 1.23–3.21), eGFR <60 (HR 2.51, 95% CI 1.87–3.37), BMI 30–34.99 (HR 1.41, 95% CI 1.08–1.85), BMI 35–39.99 (HR 1.90, 95% CI 1.38–2.62), and BMI ≥40 (HR 2.31, 95% CI 1.56–3.41). Conclusions Elevated BMI is independently associated with new-onset HF after AF ablation, with risk rising progressively across BMI categories. These patients may warrant continued attention to cardiovascular risk after ablation.
No takes yet. Share an insight, caveat, or question.
Ramadan et al. (2026) conducted a cohort in Atrial fibrillation undergoing catheter ablation (n=7,363). Elevated body mass index (BMI >=40 kg/m2) vs. Normal body mass index (BMI <25 kg/m2) was evaluated on New-onset heart failure following catheter ablation for atrial fibrillation (HR 2.31, 95% CI 1.56-3.41, p=<0.001). Severe obesity (BMI >=40 kg/m2) was independently associated with more than double the risk of new-onset heart failure after atrial fibrillation ablation compared to BMI <25 kg/m2.
Synapse has enriched 10 related papers. Consider them for comparative context: